Overview of Phase III clinical trial UKALL14 for ALL
Importance of prognostic factors in the treatment of CLL and how to assess them
Overview of the CLL13 trial: replacing chemotherapy with venetoclax-containing regimens
Julia von Tresckow
What are the genetic and environmental risk factors for chronic lymphoblastic leukemia (CLL)?
Changing epigenetic markers in CLL patients on ibrutinib